Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC. Read more about Stereotactic body radiation therapy versus sublobar resection for stage I NSCLC.
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study. Read more about Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.
Economic impact of preventing brain metastases with alectinib in ALK-positive non-small cell lung cancer. Read more about Economic impact of preventing brain metastases with alectinib in ALK-positive non-small cell lung cancer.
Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years. Read more about Lung cancer incidence trends in California by race/ethnicity, histology, sex, and neighborhood socioeconomic status: An analysis spanning 28 years.
Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study. Read more about Impact of age and comorbidity on treatment of non-small cell lung cancer recurrence following complete resection: A nationally representative cohort study.
Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population. Read more about Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.
A phase II study of saracatinib (AZD0530), a Src inhibitor, administered orally daily to patients with advanced thymic malignancies. Read more about A phase II study of saracatinib (AZD0530), a Src inhibitor, administered orally daily to patients with advanced thymic malignancies.
The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma. Read more about The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma.
Does age influence the symptom experience of lung cancer patients prior to surgery? Read more about Does age influence the symptom experience of lung cancer patients prior to surgery?
A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer. Read more about A phase II study of enzastaurin in combination with erlotinib in patients with previously treated advanced non-small cell lung cancer.
